AIG
STAB

American International Group’s Statera Biopharma, Inc. Common Stock STAB Stock Holding History

American International Group’s Portfolio STAB Stock Details STAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-37
Closed – – 4636
2016
Q1 		$0 Hold
37
– – ﹤0.01% 5154
2015
Q4 		$0 Hold
37
– – ﹤0.01% 5114
2015
Q3 		$0 Hold
37
– – ﹤0.01% 5094
2015
Q2 		$161 Hold
37
– – ﹤0.01% 5094
2015
Q1 		$132 Sell
37
-1
-3% -$4 ﹤0.01% 5013
2014
Q4 		$214 Buy
38
+13
+52% +$102 ﹤0.01% 4967
2014
Q3 		$230 Hold
25
– – ﹤0.01% 4961
2014
Q2 		$240 Hold
25
– – ﹤0.01% 4908
2014
Q1 		$341 Hold
25
– – ﹤0.01% 4800
2013
Q4 		$585 Hold
25
– – ﹤0.01% 4709
2013
Q3 		$785 Hold
25
– – ﹤0.01% 4601
2013
Q2 		$790 Buy
+25
New +$861 ﹤0.01% 4522

Other funds holding STAB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LTFS
Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
WA
Winfield Associates Cleveland, Ohio $276M AUM 15.18% 1-Year Est. Return

American International Group's STAB Position: Q2 2016 in Review

American International Group sold out of Statera Biopharma, Inc. Common Stock (STAB) in Q2 2016, closing a stake of 37 shares.

American International Group first reported a position in STAB in Q2 2013 and held it in 12 quarters. The position peaked at $790 in Q2 2013. 19 funds tracked by Wall St. Rank hold STAB as of Q2 2016.

  • American International Group reported no remaining Statera Biopharma, Inc. Common Stock position as of Q2 2016 after selling out during the quarter.
  • American International Group sold 37 Statera Biopharma, Inc. Common Stock shares in Q2 2016.
  • American International Group first reported a position in Statera Biopharma, Inc. Common Stock in Q2 2013 and held it in 12 quarters.
  • American International Group's Statera Biopharma, Inc. Common Stock position peaked at $790 in Q2 2013.
  • 19 funds tracked by Wall St. Rank held Statera Biopharma, Inc. Common Stock as of Q2 2016.

Based on American International Group's 13F filing for Q2 2016, filed 11 Aug 2016.